IL6 and triple-negative breast carcinoma: IL-6 and IL-8 play an essential role in breast tumorigenesis, associate with poor patient survival, and are implicated in the maintenance of breast CSCs and chemotherapy resistance, particularly in basal subtype and triple negative breast cancer [5, 49–51].